I have just returned from the annual European Rheumatology EULAR 2013 (#EULAR2013) meeting in Madrid. This massive conference was attended by about 14,000 delegates, with over 500 ‘posters’ per day and over 230 invited speakers. There were 10 concurrent oral sessions in the programme 4 or 5 times a day, often with very little time in between.
I can remember many conferences in the past where I felt that I hadn’t get much out of the conference, but I think that this one was better than most. Over the years I have learned that it takes a lot of preparation and focus to make the most of the experience. For what it’s worth, I’m going to share with you how a I went about my preparation this.
mobihealthnews FDA clears GlobalMed's medical imaging cloud software mobihealthnews GlobalMed CapSure Cloud Scottsdale, Arizona-based GlobalMed, a maker of connected health devices and software platforms, received FDA 510(k) clearance for its...
Naloxone is an easy-to-use, lifesaving antidote to overdose from heroin or other opioids. Used in hospitals for decades, the medication has no abuse potential, costs as little as one dollar for a lifesaving dose and can be administered with basic training. - See more at: http://naloxoneinfo.org/#sthash.wwkPsEkx.dpuf
FDA OKs System for Testing 193 Yeasts & Bacteria Known to Cause Infections ADVANCE for LPNs The FDA reviewed the VITEK MS through its de novo classification process, a regulatory pathway for some novel low-to-moderate risk medical devices that are...
In the last few years, data has changed the landscape of the healthcare public relations (PR) industry where I work as a digital specialist. The change has been largely driven by the use of digital technologies and social media.
English: Chemical structure of fostamatinib disodium (tamatinib fosdium; R-788; NSC-745942; R-935788) (Photo credit: Wikipedia) Big Pharma hardly needs to be warned of the fickle nature of drug development, but the industry received a timely reminder...
via Jonathan Benson Global Research A new vaccine for influenza has hit the market, and it is the first ever to contain genetically-modified (GM) proteins derived from insect cells. According to reports, the U.S.
"The FDA has approved initiation of a multicenter trial of the DigniCap System, a scalp-cooling device for chemotherapy-related hair loss. The trial is the second and final phase of study for the DigniCap System. A pilot study previously conducted by researchers at the University of California San Francisco and Wake Forest Baptist Medical Center found that the treatment was successful and well tolerated in the majority of women."
Metro.us New weight-loss drug available CNN (CNN) -- Nearly a year after receiving approval from the U.S. Food and Drug Administration, a new obesity drug will be available to certain patients by prescription, starting Tuesday.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.